UVA AI Diffusion Models Design Flexible Drug Molecules
Why it matters: Potentially lowers the $2.6 billion average cost of new drugs.
- Nikolay V. Dokholyan and UVA team created YuelDesign, a diffusion‑AI tool that designs drug molecules while accounting for protein flexibility.
- YuelPocket pinpoints binding sites on proteins, and YuelBond validates the chemical bonds of the generated molecules.
- The approach was reported in PNAS, J. Chem. Inf. Model., and Science Advances, showing faster, more realistic drug candidate generation.
UVA researchers led by Nikolay V. Dokholyan unveiled YuelDesign, a diffusion‑AI platform that crafts drug molecules tailored to the dynamic shapes of protein targets. Coupled with YuelPocket and YuelBond, the suite promises faster, more accurate drug design and repurposing.
